Search

everythinglearnresearchcommunity

for

Search:↓

A new drug delivery system using oil body-bound oleosin-rhFGF-10 improves wound healing and hair growth in mice.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

All medications can cause skin rashes, often without a clear cause, and better tests are needed to identify these drug-related skin issues.

Drug metabolism affects how long a drug works, its interactions, activation, and toxicity, and is influenced by genetics, diet, illness, and other drugs.

A man developed a rare skin condition and drug-induced lupus, highlighting the need for biopsy in diagnosing skin issues caused by sunlight.

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

Antibiotics often cause skin reactions, making them a major health concern.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

No cure exists for alopecia areata, and treatments are personalized.

The anti-CXCL4 antibody helps mice grow hair faster and prevents hair loss.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

Minoxidil may protect nerves and improve hair quality during paclitaxel treatment.

New physical methods like electrical currents, ultrasound, and microneedles show promise for improving drug delivery through the skin.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Hydroxychloroquine can help treat certain types of hair loss.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Korean Red Ginseng may protect against hair loss caused by chemotherapy.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

Minoxidil nanoparticles can potentially be a more effective treatment for hair growth than current treatments.

Stopping the medication infliximab and starting new treatments helped a woman's hair grow back and improved her scalp condition.